YFYudai Fujimoto

Yudai Fujimoto

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yudai Fujimoto has a total of 172 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Implications of Urinary Albumin-to-Creatinine Ratio for Subsequent Kidney Function Decline and Kidney-Related Outcomes in Patients Hospitalized for Worsening Heart Failure: Insights From the JROADHF-NEXT Registry

    by Yuka Akama, Yu Suresvar Singh, Taisuke Nakade, Yudai Fujimoto, Tomomi Ide, Keisuke Kida, Shouji Matsushima, Nobuyuki Enzan, Masataka Ikeda, Takeshi Kitai, et al.

  • Open Access

    The Hemodynamic Reversal of Delayed-Onset Radiation-Induced Constrictive Pericarditis Obtained by Pericardiectomy

    by Natsumi Kashimura, Yudai Fujimoto, Taisuke Nakade, Yuya Matsue, Tohru Minamino

    Constrictive pericarditis (CP) is often underdiagnosed, partly because of the lack of established diagnostic criteria. Exaggerated ventricular interdependence during inspiration is a hallmark physiological feature of CP. We herein report the case of a 55-year-old patient with CP who demonstrated a hemodynamic improvement following pericardiectomy. This case is characterized by two features: (1) delayed-onset CP 36 years after undergoin thoracic radiotherapy, which developed without pericardial calcification in contrast to severe aortic calcification, and (2) a postoperative improvement of inspiratory-exaggerated ventricular interdependence, documented by intracardiac pressure tracings. This case provides meaningful insight into the diagnosis and management of radiation-induced CP.


  • Acute cardiac complication in a patient with antimitochondrial M2 antibody-positive myositis on immunosuppressive therapy

    by Shuto Takahashi, Yudai Fujimoto, Takao Kato, Yuya Matsue, Tohru Minamino

  • Open Access

    Prognostic Value of Handgrip Strength in Older Patients With Heart Failure: A Post Hoc Analysis of FRAGILE‐HF

    by Yuka Akama, Taisuke Nakade, Yuya Matsue, Nobuyuki Kagiyama, Yutaka Nakamura, Yudai Fujimoto, Daichi Maeda, Hanako Inoue, Tsutomu Sunayama, Taishi Dotare, et al.

    Background: The prognostic value of handgrip strength, a simple and reliable indicator of sarcopenia, in older patients with heart failure remains uncertain. This study aimed to investigate the prognostic value of handgrip strength in hospitalized patients aged ≥65 years with heart failure. Methods: This post hoc analysis used data from FRAGILE‐HF (Prevalence and Prognostic Value of Physical and Social Frailty in Geriatric Patients Hospitalized for Heart Failure), a prospective, multicenter cohort study involving patients aged ≥65 years hospitalized for heart failure. Handgrip strength was measured before discharge using a dynamometer, with the higher value from 2 trials recorded. Measurements were standardized by dividing 28 and 18 kg for men and women, respectively, per 2019 Asian Working Group for Sarcopenia criteria. Patients were categorized into tertiles (tertile 1, highest; tertile 2, middle; and tertile 3, lowest). The primary outcome was 2‐year all‐cause death. Results: Among 1269 patients (median age, 81 years; 57.1% men), 275 died during follow‐up. Kaplan–Meier analysis revealed a stepwise increase in death across the lowest handgrip tertiles, which remained significant after multivariable adjustment (tertile 2 versus tertile 1: hazard ratio [HR], 1.64 [95% CI, 1.14–2.37]; P =0.007; tertile 3 versus tertile 1: HR, 2.03 [95% CI, 1.42–2.90]; P <0.001). The analysis using a linear model showed that the prognostic impact of reduced handgrip strength increased with age. Conclusions: Lower handgrip strength was independently associated with death in older patients with heart failure, with stronger associations observed in the oldest patients. These findings highlight the additional prognostic value of handgrip strength beyond conventional risk factors. Registration: URL: center6.umin.ac.jp ; Unique Identifier: UMIN000023929.


  • Prognostic importance of the reason for six‐minute walk test interruption in hospitalized older patients with heart failure

    by Hiroshi Saito, Daichi Maeda, Nobuyuki Kagiyama, Tsutomu Sunayama, Taishi Dotare, Yudai Fujimoto, Taisuke Nakade, Kentaro Jujo, Kazuya Saito, Kentaro Kamiya, et al.

    Aim: The six‐minute walk test (6MWT) allows patients to slow down, stop and rest as needed. However, the prognostic significance of 6MWT interruption remains unclear. Therefore, this study investigated the prognostic implications of 6MWT interruption in patients with heart failure (HF). Methods: Patients hospitalized with HF who underwent 6MWT before discharge were included. They were stratified into three groups: those who completed the 6MWT, those who interrupted the test because of dyspnea or leg fatigue and those who interrupted the test for other reasons. The primary outcome was 2‐year mortality. Results: In total, 1180 patients were analyzed; 749 completed the 6MWT, 341 interrupted it because of dyspnea or leg fatigue and 90 interrupted it for other reasons. During the 2‐year follow‐up period, 238 patients (20.2%) died. In the Kaplan–Meier analysis, 6MWT interruption due to dyspnea/leg fatigue was associated with a significantly higher 2‐year mortality rate, which remained significant even after adjustment for conventional risk factors, including the 6MWD and the Borg score measured after the 6MWT. However, 6MWT interruption for other reasons was not significantly associated with mortality. Conclusion: In hospitalized patients with HF, 6MWT interruption due to dyspnea or leg fatigue was independently associated with higher 2‐year mortality, regardless of the 6MWD. These findings suggest that 6MWT interruption might be a valuable prognostic marker for HF management. Geriatr Gerontol Int 2025; 25: 1475–1480 .

  • Wobble board instability enhances proactive postural control

    by Damian G. Kelty-Stephen, Theodore Deligiannis, Yudai Fujimoto, Ken Kiyono, Madhur Mangalam


  • Open Access

    Association Between Mineralocorticoid Receptor Antagonist Use With Worsening Renal Function and Prognosis in Patients With Acute Heart Failure

    by Yudai Fujimoto, Yasuyuki Shiraishi, Kazutaka Nogi, Shun Kohsaka, Takashi Kohno, Mitsunobu Kitamura, Yuji Nagatomo, Tomoya Ueda, Maki Nogi, Satomi Ishihara, et al.

    Background: Prognostic implications of mineralocorticoid receptor antagonist (MRA) initiation in the context of worsening renal function (WRF) in patients with acute heart failure (AHF) remain unknown. Methods: This was a post hoc analysis using data from Japanese AHF registries (NARA‐HF [Nara Registry and Analyses for Heart Failure], WET‐HF [West Tokyo Heart Failure], REALITY‐AHF [Registry Focused on Very Early Presentation and Treatment in Emergency Department of Acute Heart Failure]). MRA‐naïve patients at baseline were included, comprising 1632 patients with HF with reduced ejection fraction (HFrEF) and 2407 with heart failure with mildly reduced or preserved ejection fraction (HFmr/pEF). They were divided into 3 groups: MRA initiated without WRF (HFrEF, n=590; HFmr/pEF, n=572), MRA initiated with WRF (HFrEF, n=74; HFmr/pEF, n=100), and no MRA initiation (HFrEF, n=968; HFmr/pEF, n=1735). WRF was defined as a 0.3 mg/dL increase from admission to discharge. The composite of death or HF hospitalization after discharge was assessed. Results: During the 1‐year follow‐up, 369 and 593 events occurred in patients with HFrEF and HFmr/pEF, respectively. Overall, MRA initiation during hospitalization of AHF was independently associated with better prognosis (hazard ratio [HR], 0.81), mainly driven by HF hospitalization. Among patients with HFrEF, the groups with MRA with and without WRF showed a lower incidence of the outcome than the no‐MRA group, even after adjusting for risk factors (HR, 0.75 and 0.49, respectively). Among patients with HFmr/pEF, MRA initiation without WRF was independently associated with better prognosis (HR, 0.78), but MRA initiation with WRF was not. Conclusions: Initiating an MRA during AHF hospitalization was associated with better postdischarge outcomes in HFrEF, irrespective of creatinine elevation, whereas no such consistent association was observed in HFmr/pEF.


  • Open Access

    Euglycemic Diabetic Ketoacidosis in a Patient with Type 2 Diabetes and Preserved Insulin Secretion on Empagliflozin

    by Yumiko Yoshida, Yudai Fujimoto, Hirokazu Konishi, Eiichiro Sato, Hiroshi Iwata, Shohei Ouchi, Ryo Naito, Hidemori Hayashi, Yuya Matsue, Tohru Minamino

    As the use of sodium-glucose cotransporter 2 (SGLT2) inhibitors has become widespread, euglycemic diabetic ketoacidosis (EDKA), a rare but notable complication associated with SGLT2 inhibitor use, is gaining attention, although the underlying mechanisms of SGLT2 inhibitor-associated EDKA remain unclear. This report describes the case of a 77-year-old male with type 2 diabetes mellitus on an SGLT2 inhibitor who developed EDKA just after undergoing percutaneous coronary intervention following acute myocardial infarction, with only one day of fasting, despite sufficient insulin secretion. Our case report provides valuable insights into the mechanism and management of SGLT2 inhibitor-associated EDKA in urgent clinical settings.


  • Open Access

    Effect of an Enteral Formula Enriched With ω-3 Fatty Acids, Carnitine, and Vitamin D on Body Weight, Heart Weight, and Blood Biochemical Parameters in a Dahl Rat Heart Failure Model

    by Yoshikazu Ryuno, Jun-Ichi Kobayashi, Yudai Fujimoto, Taishi Dotare, Yuya Matsue, Yoshihito Iwanami

    Malnutrition is known to worsen the prognosis of chronic heart failure (HF). To gain information that may be helpful in establishing appropriate nutritional interventions for chronic HF, this study was performed to investigate the efficacy of nutritional management with 2 enteral formulas, EH, with a standard nutritional composition, and ER, fortified with omega-3 fatty acids, vitamin D, and carnitine. Experiments were performed in a Dahl rat HF model. After being fed a standard rodent feed (MF) containing 8% NaCl (high salt-MF [HS-MF]) from 6 to 11 weeks of age, rats were assigned to freeze-dried EH or ER diets with an NaCl concentration of 8% (HS-ER or HS-EH) until 18 weeks of age. Serum albumin was significantly higher at 14 and 17 weeks of age in rats fed the HS-ER and HS-EH diets compared with those remaining on the HS-MF diet. Body weight was also significantly higher at 14 and 17 weeks of age in animals fed the HS-ER diet, showing that nutritional deterioration was prevented. In addition, heart weight was significantly lower at 18 weeks of age in the HS-ER group than that in the HS-MF group, suggesting that cardiac hypertrophy was prevented. This study demonstrated improved nutritional status in a HF model in Dahl rats presumably owing to differences in nutritional composition in the diets. Future studies are needed to explore optimal nutritional management with enteral formulas in patients with chronic HF.